Physician profile
Edwin Alejandro
NPI 1649343369
$3,096.41
in general payments reported to CMS, 2019-2025
17 companies · $405 in 2025
The $405 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $626 · 2020: $388 · 2021: $462 · 2022: $425 · 2023: $456 · 2024: $335 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,195.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $595.76 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $570.94 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $557.31 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $262.65 | 2019-2025 | Eliquis |
| Amgen INC. | $240.10 | 2019-2023 | Repatha |
| Astrazeneca Pharmaceuticals Lp | $174.44 | 2019-2023 | Farxiga |
| Abbott Laboratories | $150.12 | 2019-2025 | Jot Dx, Mitraclip |
| Pbg Puerto Rico LLC | $129.44 | 2019-2025 | |
| Terumo Medical Corporation | $117.15 | 2025 | Access |
| Eli Lilly Export S.A. Puerto Rico Branch | $93.18 | 2019-2025 | Mounjaro, Zepbound |
| Sanofi-Aventis U.S. LLC | $63.00 | 2020-2022 | |
| Pfizer INC. | $30.50 | 2021 | |
| Biotronik INC. | $24.49 | 2019 | |
| Medtronic, INC. | $22.50 | 2024 | Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $22.47 | 2023 | Watchman Access System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $22.36 | 2021 | |
| Merck Sharp & Dohme LLC | $20.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Alejandro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.